Un compus din ciupercile halucinogene ar putea preveni afectarea nervilor provocată de chimioterapie

A compound from hallucinogenic mushrooms may protect nerves from chemotherapy-induced peripheral neuropathy, as shown in a mouse study. Mice treated with psilocybin before chemotherapy did not develop pain sensitivity or nerve fiber degradation. This protection did not hinder chemotherapy's tumor-reducing effects. The substance appears to maintain mitochondrial movement, crucial for nerve health. Researchers also tested tabernanthalog, which showed similar protective effects without causing hallucinations. A clinical trial on humans is planned to assess safety and efficacy in cancer patients.